An exponential rise in the prevalence of diabetic retinopathy points to the need for more vigilance in vision screenings for people with diabetes, experts said.
The prevalence of vision-threatening retinopathy in people with diabetes has increased exponentially in the past decade, most acutely among younger adults and Hispanic and Black populations, an analysis of a large electronic database has shown.
Men had greater increases than women, with White men having the greatest prevalence in 2022 — 38.6 cases per 100,000. "By 30 years and older, the prevalence began to differentiate by racial and ethnicity groups, with Hispanic males and females having the largest prevalence followed by Black males and females," the researchers wrote.
"The emergency declarations, certainly among the Medicaid population and perhaps among other populations, may have made it so people kept their insurance when they wouldn't have had their insurance otherwise," Rein said."Also, the Affordable Care Act went into effect and increased the number of people with insurance in the country, allowing more people to visit the doctor and be evaluated for diabetic retinopathy, when in the past maybe they would not have been.
Diabetic Retinopathy Retinopathy Diabetes Mellitus Retinal Disease Insurance Health Care Reform Healthcare Reform Practice Management Revenue Electronic Health Records Electronic Health Record EHR Health Insurance Vision Screening Eye Examination Pandemic Preventive Screening Screening Vision Care And Maintenance ACA Obamacare
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Risk Factors for Incident Diabetic Retinopathy in T1DDuration of diabetes, systemic comorbidities, and use of medications to reduce blood pressure are common markers for present and incident DR in patients with T1D.
Read more »
Anti-VEGF Monotherapy is a Safe Alternative to Laser in Diabetic RetinopathyAnti-VEGF monotherapy can be an alternative to laser treatment in patients with proliferative diabetic retinopathy.
Read more »
Trial: Fenofibrate Slows Diabetic Retinopathy ProgressionOld lipid drug holds new promise for reducing the need for retinal laser or intravitreal injections.
Read more »
Less Diabetic Retinopathy, More Macular Degeneration?Study finds inverse relationships between age-related macular edema and diabetic retinopathy severity, as well as glycemia and lipid levels.
Read more »
Today's mortgage rates rise for 15- and 30-year ratesMortgage rates fluctuate almost daily based on economic conditions. Here are today’s mortgage rates and what you need to know about getting the best rate.
Read more »
Today's mortgage rates continue to hold steady for 15- and 30-year ratesMortgage rates fluctuate almost daily based on economic conditions. Here are today’s mortgage rates and what you need to know about getting the best rate.
Read more »